Correspondence 0001493152-23-022038 from Ocean Biomedical, Inc. (OCEA, OCEAW) (CIK 0001869974) (OCEA)
Ocean Biomedical, Inc. (OCEA, OCEAW) (CIK 0001869974)
Date: June 21, 2023 · CIK: 0001869974 · Accession: 0001493152-23-022038
AI Filing Summary & Sentiment
File numbers found in text: 333-271392
Letter
Claverick St., Room 325
Providence, Rhode Island 02903
June 21, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Attn: Joe McCann and Arzhang Navai
Re: Ocean Biomedical, Inc.
Registration Statement on Form S-1
File No. 333-271392
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effectiveness of the above-captioned Registration Statement on Form S-1 be accelerated so that the same will become effective at 4:30 p.m. Eastern Time on June 22, 2023, or as soon thereafter as practicable.
Very
truly yours,
OCEAN
BIOMEDICAL, INC.
Show Raw Text
CORRESP
1
filename1.htm
55
Claverick St., Room 325
Providence,
Rhode Island 02903
June
21, 2023
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attn:
Joe McCann and Arzhang Navai
Re:
Ocean
Biomedical, Inc.
Registration
Statement on Form S-1
File
No. 333-271392
Ladies
and Gentleman:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effectiveness of the above-captioned
Registration Statement on Form S-1 be accelerated so that the same will become effective at 4:30 p.m. Eastern Time on June 22, 2023,
or as soon thereafter as practicable.
Very
truly yours,
OCEAN
BIOMEDICAL, INC.
By:
/s/
Elizabeth Ng
Name:
Elizabeth
Ng
Title:
Chief
Executive Officer
cc:
Kate
Bechen, Esq.
Thomas
S. Vaughn, Esq.
Joseph
R. DeHondt, Esq.